United States Conjugated Drug Market Report 2016

September 2016 | 124 pages | ID: U1FB7735FE7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Conjugated Drug

Revenue, means the sales value of Conjugated Drug

This report studies sales (consumption) of Conjugated Drug in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• CSL Ltd. (Australia)
• Grifols S.A (Spain)
• Baxalta Incorporated (U.S.)
• Octapharma AG (Switzerland)
• Kedrion S.p.A (Italy)
• China Biologic Products, Inc. (China)
• Biotest AG (Germany)
• LFB S.A (France)
• Bio Product Laboratory Ltd. (U.K.)
• Sanquin (Netherlands)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Conjugated Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Conjugated Drug Market Report 2016

1 CONJUGATED DRUG OVERVIEW

1.1 Product Overview and Scope of Conjugated Drug
1.2 Classification of Conjugated Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Conjugated Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Conjugated Drug (2011-2021)
  1.4.1 USA Conjugated Drug Sales and Growth Rate (2011-2021)
  1.4.2 USA Conjugated Drug Revenue and Growth Rate (2011-2021)

2 USA CONJUGATED DRUG COMPETITION BY MANUFACTURERS

2.1 USA Conjugated Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Conjugated Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Conjugated Drug Average Price by Manufactures (2015 and 2016)
2.4 Conjugated Drug Market Competitive Situation and Trends
  2.4.1 Conjugated Drug Market Concentration Rate
  2.4.2 Conjugated Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA CONJUGATED DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Conjugated Drug Sales and Market Share by Type (2011-2016)
3.2 USA Conjugated Drug Revenue and Market Share by Type (2011-2016)
3.3 USA Conjugated Drug Price by Type (2011-2016)
3.4 USA Conjugated Drug Sales Growth Rate by Type (2011-2016)

4 USA CONJUGATED DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Conjugated Drug Sales and Market Share by Application (2011-2016)
4.2 USA Conjugated Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA CONJUGATED DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 CSL Ltd. (Australia)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Conjugated Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 CSL Ltd. (Australia) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Grifols S.A (Spain)
  5.2.2 Conjugated Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Grifols S.A (Spain) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Baxalta Incorporated (U.S.)
  5.3.2 Conjugated Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Baxalta Incorporated (U.S.) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Octapharma AG (Switzerland)
  5.4.2 Conjugated Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Octapharma AG (Switzerland) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Kedrion S.p.A (Italy)
  5.5.2 Conjugated Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Kedrion S.p.A (Italy) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 China Biologic Products, Inc. (China)
  5.6.2 Conjugated Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 China Biologic Products, Inc. (China) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Biotest AG (Germany)
  5.7.2 Conjugated Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Biotest AG (Germany) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 LFB S.A (France)
  5.8.2 Conjugated Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 LFB S.A (France) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bio Product Laboratory Ltd. (U.K.)
  5.9.2 Conjugated Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bio Product Laboratory Ltd. (U.K.) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Sanquin (Netherlands)
  5.10.2 Conjugated Drug Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Sanquin (Netherlands) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 CONJUGATED DRUG MANUFACTURING COST ANALYSIS

6.1 Conjugated Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Conjugated Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Conjugated Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Conjugated Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA CONJUGATED DRUG MARKET FORECAST (2016-2021)

10.1 USA Conjugated Drug Sales, Revenue Forecast (2016-2021)
10.2 USA Conjugated Drug Sales Forecast by Type (2016-2021)
10.3 USA Conjugated Drug Sales Forecast by Application (2016-2021)
10.4 Conjugated Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Conjugated Drug
Table Classification of Conjugated Drug
Figure USA Sales Market Share of Conjugated Drug by Type in 2015
Table Application of Conjugated Drug
Figure USA Sales Market Share of Conjugated Drug by Application in 2015
Figure USA Conjugated Drug Sales and Growth Rate (2011-2021)
Figure USA Conjugated Drug Revenue and Growth Rate (2011-2021)
Table USA Conjugated Drug Sales of Key Manufacturers (2015 and 2016)
Table USA Conjugated Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjugated Drug Sales Share by Manufacturers
Figure 2016 Conjugated Drug Sales Share by Manufacturers
Table USA Conjugated Drug Revenue by Manufacturers (2015 and 2016)
Table USA Conjugated Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Conjugated Drug Revenue Share by Manufacturers
Table 2016 USA Conjugated Drug Revenue Share by Manufacturers
Table USA Market Conjugated Drug Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Conjugated Drug Average Price of Key Manufacturers in 2015
Figure Conjugated Drug Market Share of Top 3 Manufacturers
Figure Conjugated Drug Market Share of Top 5 Manufacturers
Table USA Conjugated Drug Sales by Type (2011-2016)
Table USA Conjugated Drug Sales Share by Type (2011-2016)
Figure USA Conjugated Drug Sales Market Share by Type in 2015
Table USA Conjugated Drug Revenue and Market Share by Type (2011-2016)
Table USA Conjugated Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Conjugated Drug by Type (2011-2016)
Table USA Conjugated Drug Price by Type (2011-2016)
Figure USA Conjugated Drug Sales Growth Rate by Type (2011-2016)
Table USA Conjugated Drug Sales by Application (2011-2016)
Table USA Conjugated Drug Sales Market Share by Application (2011-2016)
Figure USA Conjugated Drug Sales Market Share by Application in 2015
Table USA Conjugated Drug Sales Growth Rate by Application (2011-2016)
Figure USA Conjugated Drug Sales Growth Rate by Application (2011-2016)
Table CSL Ltd. (Australia) Basic Information List
Table CSL Ltd. (Australia) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Ltd. (Australia) Conjugated Drug Sales Market Share (2011-2016)
Table Grifols S.A (Spain) Basic Information List
Table Grifols S.A (Spain) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols S.A (Spain) Conjugated Drug Sales Market Share (2011-2016)
Table Baxalta Incorporated (U.S.) Basic Information List
Table Baxalta Incorporated (U.S.) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxalta Incorporated (U.S.) Conjugated Drug Sales Market Share (2011-2016)
Table Octapharma AG (Switzerland) Basic Information List
Table Octapharma AG (Switzerland) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma AG (Switzerland) Conjugated Drug Sales Market Share (2011-2016)
Table Kedrion S.p.A (Italy) Basic Information List
Table Kedrion S.p.A (Italy) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion S.p.A (Italy) Conjugated Drug Sales Market Share (2011-2016)
Table China Biologic Products, Inc. (China) Basic Information List
Table China Biologic Products, Inc. (China) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologic Products, Inc. (China) Conjugated Drug Sales Market Share (2011-2016)
Table Biotest AG (Germany) Basic Information List
Table Biotest AG (Germany) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotest AG (Germany) Conjugated Drug Sales Market Share (2011-2016)
Table LFB S.A (France) Basic Information List
Table LFB S.A (France) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table LFB S.A (France) Conjugated Drug Sales Market Share (2011-2016)
Table Bio Product Laboratory Ltd. (U.K.) Basic Information List
Table Bio Product Laboratory Ltd. (U.K.) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio Product Laboratory Ltd. (U.K.) Conjugated Drug Sales Market Share (2011-2016)
Table Sanquin (Netherlands) Basic Information List
Table Sanquin (Netherlands) Conjugated Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanquin (Netherlands) Conjugated Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Conjugated Drug
Figure Manufacturing Process Analysis of Conjugated Drug
Figure Conjugated Drug Industrial Chain Analysis
Table Raw Materials Sources of Conjugated Drug Major Manufacturers in 2015
Table Major Buyers of Conjugated Drug
Table Distributors/Traders List
Figure USA Conjugated Drug Production and Growth Rate Forecast (2016-2021)
Figure USA Conjugated Drug Revenue and Growth Rate Forecast (2016-2021)
Table USA Conjugated Drug Production Forecast by Type (2016-2021)
Table USA Conjugated Drug Consumption Forecast by Application (2016-2021)